Needle Free Injection Market by Technology (Laser-powered, Spring-based & Jet-based), Competitive Analysis by Top 10 Players and 2023 Forecast

“Needle Free Injection Market”
The Worldwide Needle Free Injection Market is predicted to touch USD 25,057.4 million by 2023 from USD 10,377.7 million in 2016, expanding at an astounding CAGR of 15.8% during the forecast period (2018-2023). High prevalence of diabetes is the primary factor driving the market.

Needle Free Injection Market Highlights:

Needle free injections are syringes which deliver drugs through direct contact with the skin instead of a hypodermic needle. They can be used by children, adults, and patients with allergic conditions without any doctor supervision. It can prevent needle stick injuries, which is a common factor of disease transmission. Increasing incidence of diabetes is anticipated to induce market demand in the coming years. But high cost of these devices and cross-contamination risks can deter market growth.

The Global Needle Free Injection Market is anticipated to reach USD 25,057.4 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2018-2023). Prevalence of various chronic diseases is propelling the need for needle free injections. Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care is projected to drive market growth over the forecast period 2018-2023.

Get Exclusive Sample Copy @ .

Players Covered

CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D’Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group are prominent players in the needle free injection market.

The report offers comprehensive profiles on these market players and assesses their current standing in the needle free injection market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.

Major applications include oncology, vaccine, insulin delivery, and others. The insulin delivery application can grow robustly owing to high numbers of diabetics requiring insulin shots. On the other hand, the vaccination segment is touted to grow rapidly owing to various government campaigns vouching for the benefits of vaccines. End-users comprise ambulatory surgical centers, hospital & clinics, homecare settings, and others. The hospital and clinics segment is anticipated to dominate the needle free injection market owing to rising demand for painless solutions amid prevalence of cancer and other maladies.

Analysis Period

  • Base Year – 2017
  • Projection Period – From 2018 to 2023
  • Market Denomination – USD Million
  • Conversion Rate – Considered as per the respective financial years

Intended Audience

  • Government Research Institutes
  • Research and Development (R&D) Companies
  • Medical Devices Companies
  • Academic Institutes and Universities

Needle Free Injection Market Product Type

  • Prefilled Needle Free Injectors
  • Fillable Needle Free Injectors


  • Laser-powered
  • Spring-based
  • Jet-based


  • Disposable Needle Free Injectors
  • Reusable Needle Free Injectors

Type of Medication

  • Liquid-based Needle Free Injectors
  • Powder-based Needle Free Injectors
  • Projectile/Depot-based Needle Free Injectors

Site of Delivery

  • Intradermal Injectors
  • Intramuscular Injectors
  • Subcutaneous Injectors

Regional Market Summary

The global needle free injection market, by regions, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas accounted for 34.5% share of the market owing to constant technological advances in pharmaceutical and biotechnology sectors. Increasing demand for self-administering devices, prevalence of chronic diseases, and investments by players in the medical sector can propel its growth over the forecast period. Europe and APAC markets are anticipated to display steady growth rates respectively.

Ask To Experts @ .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India